FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to contrast agent of the structural formula:
,
where J is O; Y is carbon; K and L are independently selected from hydrogen and C1-C6 alkyl; M is selected from hydrogen, C1-C6 alkyloxy or C1-C6 alkyl, unsubstituted or substituted 18F; T and U together with carbon atoms, to which they are attached, form a six-membered aromatic ring, which is unsubstituted or substituted 18F; R21, R22 and R34 are independently selected from hydrogen and fragment 18F; R23, R24, R25 and R26 are hydrogen; n=2; wherein, at least one 18F is present in the structure of said contrast agent being an image providing fragment. Invention also relates to the use of said contrast agent, a composition or diagnostic kit based on it for detection, visualization and/or monitoring of myocardial perfusion.
EFFECT: group of inventions provides an extension of the arsenal of diagnostic markers to obtain an image of the myocardium blood supply.
9 cl, 55 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PYRROLIDINE DERIVATIVES AS PPAR AGONISTS | 2017 |
|
RU2711991C1 |
| MONOCYCLIC PYRIDINE DERIVATIVE | 2014 |
|
RU2645352C2 |
| IMIDAZOPIRASOTHINES AS PDE1 INHIBITORS | 2016 |
|
RU2712219C2 |
| DERIVATIVES OF PYRROLOPYRIMIDINE USEFUL AS JAK-KINASES INHIBITORS | 2012 |
|
RU2618673C2 |
| NOVEL PRECURSORS OF GLUTAMATE DERIVATIVES | 2012 |
|
RU2600981C2 |
| TRICYCLIC INDOLE DERIVATIVES AS PBR LIGANDS | 2010 |
|
RU2525196C2 |
| CLASS OF BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUNDS FOR TARGETED DESTRUCTION OF ANDROGEN RECEPTORS AND USE THEREOF | 2020 |
|
RU2825000C2 |
| 1,2,3,4-TETRAHYDROQUINOXALINE DERIVATIVE, METHOD FOR ITS OBTAINING AND ITS APPLICATION | 2019 |
|
RU2804127C2 |
| REGULATORS-DERIVATIVES OF STEROIDS, METHODS OF THEIR OBTAINING AND THEIR USE | 2019 |
|
RU2797408C2 |
| POLYHETEROCYCLIC COMPOUNDS AND USE THEREOF AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS | 2005 |
|
RU2381226C2 |
